Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma

Evidence supporting rechallenge in patients responding to first exposure to trabectedin is limited. We report on a 39-year-old woman with advanced high-grade undifferentiated sarcoma (US) retreated twice with trabectedin after first response. The patient presented in June 2006 with an abdominal mass...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Anticancer Drugs
Główni autorzy: Baldi, Giacomo G., Di Donato, Samantha, Fargnoli, Rossana, Dona, Manjola, Bertulli, Rossella, Parisi, Elisabetta, Fantini, Lorenzo, Sbaraglia, Marta, Panella, Mauro
Format: Artigo
Język:Inglês
Wydane: Lippincott Williams & Wilkins 2016
Hasła przedmiotowe:
Case Reports
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010279/
https://ncbi.nlm.nih.gov/pubmed/27348763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000398
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy